Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome  Nassrene Y. Elmadhun, MD, Antonio D.

Slides:



Advertisements
Similar presentations
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Improving Glucose Metabolism With Resveratrol in.
Advertisements

Expression of LKB1 tumor suppressor in non–small cell lung cancer determines sensitivity to 2-deoxyglucose  Landon J. Inge, PhD, Keith D. Coon, PhD, Michael.
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data  L. Nesti, A. Natali  Nutrition, Metabolism and.
Ashraf A. Sabe, MD, Nassrene Y. Elmadhun, MD, Rahul S
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Hypercholesterolemia and chronic ischemia alter myocardial responses to selective cyclooxygenase-2 inhibition  Louis M. Chu, MD, Michael P. Robich, MD,
Leptin and insulin signalling pathways in the Arc.
Do Diabetes Drugs Modify the Risk of Pancreatic Cancer?
Expression of LKB1 tumor suppressor in non–small cell lung cancer determines sensitivity to 2-deoxyglucose  Landon J. Inge, PhD, Keith D. Coon, PhD, Michael.
Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1  Krishna K. Singh, PhD, Praphulla C. Shukla, PhD,
Antonio D. Lassaletta, MD, Louis M. Chu, MD, Frank W. Sellke, MD 
Personalizing Therapy for Colorectal Cancer
Figure 2 Intracellular actions of metformin
Is hyperglycemia bad for the heart during acute ischemia?
Personalizing Therapy for Colorectal Cancer
Nat. Rev. Endocrinol. doi: /nrendo
Neel R. Sodha, MD, Frank W. Sellke, MD 
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Intrinsic cardiac stem cells are essential for regeneration
Abracadabra I, II…HeartMate 3?
Form ever follows function
A new approach: Ischemic mitral regurgitation guidelines by and for surgeons  Patrick M. McCarthy, MD  The Journal of Thoracic and Cardiovascular Surgery 
Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia  Ashraf A. Sabe, MD, Brittany.
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
Differential effects of atorvastatin on autophagy in ischemic and nonischemic myocardium in Ossabaw swine with metabolic syndrome  Ashraf A. Sabe, MD,
The lord of the rings  Antonio Miceli, MD, PhD 
Erythropoietin activates the phosporylated cAMP [adenosine 3′5′ cyclic monophosphate] response element-binding protein pathway and attenuates delayed.
The unintended consequences in clinical research
Estrogen Receptors and the Metabolic Network
Konstantinos G. Michalakis, M.D., James H. Segars, M.D. 
Alcohol and the Heart: A Proteomics Analysis of Pericardium and Myocardium in a Swine Model of Myocardial Ischemia  Nassrene Y. Elmadhun, MD, Ahmed A.
Atorvastatin increases oxidative stress and modulates angiogenesis in Ossabaw swine with the metabolic syndrome  Nassrene Y. Elmadhun, MD, Antonio D.
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Support Your Specialty
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Military surgeons just want to have fun
Do we need a bibliometrician to know which way the wind is blowing?
Replicating the success of mitral valve repair in the aortic valve
Fueling the heart: Shifting the myocardial metabolome by targeting endothelial autophagy  Nicholas D. Andersen, MD  The Journal of Thoracic and Cardiovascular.
Frank C. Spencer, MD, FACS, pioneering cardiothoracic surgeon
A fate worse than death  Jennifer S. Lawton, MD 
Cardiothoracic surgery: A specialty divided or as one
Simon Ekman, MD, PhD, Murry W. Wynes, PhD, Fred R. Hirsch, MD, PhD 
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Prognosis and “granularity”: Building on staging foundations?
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
Early extubation after cardiac surgery: The evolution continues
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tissue valve, nitinol stent, or storage solution
The future of cardiac surgery training: A survival guide
Apparently, size matters…in congenital heart disease and brain injury
Ventricular assistant in restrictive cardiomyopathy: Making the right connection  Robert D.B. Jaquiss, MD  The Journal of Thoracic and Cardiovascular Surgery 
When should the elephant (frozen elephant trunk) enter the room (aorta)?  Frank A. Baciewicz, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume.
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
Should it stay or should it go?
The Journal of Thoracic and Cardiovascular Surgery
“The more things change…”: The challenges ahead
Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know  Harold L. Lazar,
First in line for robotic surgery: Would you want to know?
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Preoperative PFTs: The answer is blowing in the wind
The evolution of cardiothoracic critical care
Of mice and men… The Journal of Thoracic and Cardiovascular Surgery
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Journal changes and initiatives
Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression 
Presentation transcript:

Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome  Nassrene Y. Elmadhun, MD, Antonio D. Lassaletta, MD, Louis M. Chu, MD, Frank W. Sellke, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 1, Pages 258-266 (January 2013) DOI: 10.1016/j.jtcvs.2012.09.028 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Comparative BMI and serum insulin levels in Ossabaw control (OC), Ossabaw high cholesterol (OHC), Ossabaw high cholesterol with metformin (OHCM). *Bonferroni P < .05. **Bonferroni P < .01. BMI, Body mass index. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 258-266DOI: (10.1016/j.jtcvs.2012.09.028) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Protein expression in ischemic myocardium. The ratio of phosphorylated to total protein expression calculated for proteins in the insulin signaling pathway. *Bonferroni P < .001. IRS1, Insulin receptor substrate 1; IRS2, insulin receptor substrate 2; pIRS1, phosphorylated insulin receptor substrate 1; pIRS2, phosphorylated insulin receptor substrate 2; AKT, protein kinase B; pAKT, phosphorylated protein kinase B; MTOR, mammalian target of rapamycin; pMTOR, phosphorylated mammalian target of rapamycin; AMPK, adenosine monophosphate-activated protein kinase; pAMPK, phosphorylated adenosine monophosphate-activated protein kinase; FOX01, foxhead box 01; pFOX01, phosphorylated foxhead box 01; OC, Ossabaw control; OHC, Ossabaw high cholesterol; OHCM, Ossabaw high cholesterol with metformin. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 258-266DOI: (10.1016/j.jtcvs.2012.09.028) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Histologic analysis of ischemic cardiac tissue. A, Immunofluorescence staining for GLUT1. Red staining represents GLUT1. B, Periodic acid–Schiff staining for cardiomyocyte glycogen stores. C, GLUT1 density analysis. *Bonferroni P < .01. **Bonferroni P < .001. OC, Ossabaw control; OHC, Ossabaw high cholesterol; OHCM, Ossabaw high cholesterol with metformin; GLUT1, glucose transporter 1; PAS, periodic acid-Schiff. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 258-266DOI: (10.1016/j.jtcvs.2012.09.028) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Insulin signaling transduction. The effects of insulin on glucose uptake and apoptosis/survival presented here are discussed in detail in the text. MTP, Mitochondrial transition pore; FKHR, forkhead transcription factors; IRS, insulin receptor substrate; AKT, protein kinase B; MTOR, mammalian target of rapamycin; AMPK, adenosine monophosphate-activated protein kinase; RBP4, retinol binding protein 4; AMP, adenosine monophosphate; IR, insulin receptor; p13k, phosphoinostitide 3-kinase; PIP2, phosphatidylinostitol biphosphate; PIP3, phosphatidylinostitol triphospate; PDK1, 3-phosphoinostitide–dependent kinase 1; GLUT4, glucose transporter 4; GLUT1, glucose transporter 1; NFkB, nuclear factor kappa B; BAD, Bcl-2–associated death promoter; BAX, Bcl-2–associated X protien; FOX01, foxhead box 01. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 258-266DOI: (10.1016/j.jtcvs.2012.09.028) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions